Mukhtar Muhammad Dauda, Rufa'i Fatihu Ahmad, Yola Abdurrahaman Umar, Babba Nafisa Ibrahim, Baecker Daniel
Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Bayero University Kano, Gwarzo Road, Kano PMB 3011, Nigeria.
Kano Liaison Office, Nigerian Institute for Trypanosomiasis (and Onchocerciasis) Research, Surame Road, Kaduna PMB 2077, Nigeria.
Antibiotics (Basel). 2023 Oct 31;12(11):1582. doi: 10.3390/antibiotics12111582.
The worsening of antibiotic resistance is a multifactorial process. One aspect of this is the counterfeiting of antibiotic medications. This is supposed to be particularly high in developing countries, including Nigeria. Therefore, the potency of some antibiotic drugs dispensed in community pharmacies in Gwale, Kano, Nigeria, was investigated in this case study. Three products, each from different manufacturers, with the active ingredients of ceftriaxone, gentamicin, ciprofloxacin, and metronidazole, respectively, were included in this study. By means of a disc-diffusion assay, the effect against the typed strains (ATCC 25923) and (ATCC 25922) as well as isolated from soil was tested. Clinical isolates of and were also used. While antibiotics, with the exception of ciprofloxacin-containing preparations against , showed acceptable efficacy against the typed strains by comparison with the clinical science laboratory references, a predominant failure was observed with the clinical isolates. Thus, the investigated drug preparations can be considered of acceptable quality for the treatment of susceptible bacterial infections. This excludes counterfeits in the sampled preparations. However, the insufficient efficacy against clinical isolates further documents the severity of nosocomial bacteria.
抗生素耐药性的恶化是一个多因素过程。其中一个方面是抗生素药物的假冒问题。据推测,在包括尼日利亚在内的发展中国家,这种情况尤为严重。因此,在本案例研究中,对尼日利亚卡诺州瓜尔社区药房配出的一些抗生素药物的效力进行了调查。本研究纳入了三种产品,每种产品来自不同制造商,其活性成分分别为头孢曲松、庆大霉素、环丙沙星和甲硝唑。通过纸片扩散法,测试了这些产品对标准菌株(ATCC 25923)和(ATCC 25922)以及从土壤中分离出的菌株的抗菌效果。还使用了临床分离出的菌株。与临床科学实验室参考标准相比,除含环丙沙星制剂对某菌株外,其他抗生素对标准菌株显示出可接受的疗效,但对临床分离菌株观察到主要疗效不佳。因此,所调查的药物制剂可被认为质量可接受,可用于治疗敏感细菌感染。这排除了所采样制剂中的假冒产品。然而,对临床分离菌株疗效不足进一步证明了医院细菌问题的严重性。